Beam Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Beam Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Beam Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Beam Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $14M | 523k | 27.22 |
| 2023-09-30 | $16M | 663k | 24.05 |
| 2023-06-30 | $23M | 708k | 31.93 |
| 2023-03-31 | $22M | 722k | 30.71 |
| 2022-12-31 | $29M | 741k | 39.25 |
| 2022-06-30 | $29M | 739k | 38.63 |
| 2022-03-31 | $43M | 743k | 57.37 |
| 2021-12-31 | $58M | 733k | 79.73 |
| 2021-03-31 | $28M | 355k | 80.04 |
| 2020-12-31 | $19M | 235k | 81.63 |
| 2020-09-30 | $4.3M | 175k | 24.71 |
| 2020-06-30 | $1.1M | 41k | 28.01 |
| 2020-03-31 | $723k | 40k | 17.99 |